Genetics: Ethics, Law And Policy (American Casebook Series)
Description:
This is the revised edition of the casebook, Genetics: Ethics, Law, and Policy, which has been used successfully in law schools in both the seminar and course context. It is authored by three of the nation s leading experts on genetic ethics, law and policy. Students enjoy the course because of the topicality of the subjects, many of which they hear about in the news (gene discoveries, embryo stem cell research). Faculty members enjoy teaching from the book because of the excellent teaching manual and because they can link it to other topics the casebook covers issues in health law, employment law, insurance law, criminal law, family law, and other fields. The casebook is supplemented regularly on the TWEN website, so that it is always current. A background in genetics is not required for either students or teachers. The casebook and teachers? manual are written so that the casebook can be used for undergraduate courses or courses for the health professions, for public health, or for public policy.
Best prices to buy, sell, or rent ISBN 9780314162939
Frequently Asked Questions about Genetics: Ethics, Law And Policy (American Casebook Series)
You can buy the Genetics: Ethics, Law And Policy (American Casebook Series) book at one of 20+ online bookstores with BookScouter, the website that helps find the best deal across the web. Currently, the best offer comes from and is $ for the .
The price for the book starts from $38.99 on Amazon and is available from 6 sellers at the moment.
If you’re interested in selling back the Genetics: Ethics, Law And Policy (American Casebook Series) book, you can always look up BookScouter for the best deal. BookScouter checks 30+ buyback vendors with a single search and gives you actual information on buyback pricing instantly.
As for the Genetics: Ethics, Law And Policy (American Casebook Series) book, the best buyback offer comes from and is $ for the book in good condition.
Not enough insights yet.
Not enough insights yet.